Bernd R. Seizinger - 22 Sep 2023 Form 4 Insider Report for Aptose Biosciences Inc. (APTOF)

Role
Director
Signature
/s/ Bernd R. Seizinger
Issuer symbol
APTOF
Transactions as of
22 Sep 2023
Net transactions value
+$53,380
Form type
4
Filing time
25 Sep 2023, 17:03:39 UTC
Previous filing
24 Aug 2023
Next filing
07 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APTO Common Shares Purchase $53,380 +17,000 $3.14 17,000 22 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.13 to $3.14, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc.., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Remarks:

Exhibit 24.2 Power of Attorney